Literature DB >> 31490750

Hyaluronan Fragmentation During Inflammatory Pathologies: A Signal that Empowers Tissue Damage.

Angela Avenoso1, Giuseppe Bruschetta2, Angela D Ascola3, Michele Scuruchi3, Giuseppe Mandraffino3, Antonino Saitta3, Salvatore Campo1, Giuseppe M Campo3.   

Abstract

The mechanisms that modulate the response to tissue injury are not fully understood. Abnormalities in the repair response are associated with a variety of chronic disease states characterized by inflammation, followed subsequently by excessive ECM deposition. As cell-matrix interactions are able to regulate cellular homeostasis, modification of ECM integrity appears to be an unspecific factor in promoting the onset and progression of inflammatory diseases. Evidence is emerging to show that endogenous ECM molecules supply signals to damage tissues and cells in order to promote further ECM degradation and inflammation progression. Several investigations have been confirmed that HA fragments of different molecular sizes exhibit different biological effects and responses. In fact, the increased deposition of HA into the ECM is a strong hallmark of inflammation processes. In the context of inflammatory pathologies, highly polymerized HA is broken down into small components, which are able to exacerbate the inflammatory response by inducing the release of various detrimental mediators such as reactive oxygen species, cytokines, chemokines and destructive enzymes and by facilitating the recruitment of leukocytes. However, strategies involving the modulation of the HA fragment with specific receptors on cell surface could represent different promising effects for therapeutic scope. This review will focus on the inflammation action of small HA fragments in recent years obtained by in vivo reports. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Hyaluronan fragments; cytokines; extracellular matrix; inflammation; toll-like receptors; transcription factors.

Mesh:

Substances:

Year:  2020        PMID: 31490750     DOI: 10.2174/1389557519666190906115619

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  9 in total

Review 1.  Proteoglycans in Toll-like receptor responses and innate immunity.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-08       Impact factor: 5.282

2.  CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane.

Authors:  Michel G Malaise; Dominique de Seny; Céline Deroyer; Christophe Poulet; Geneviève Paulissen; Federica Ciregia; Olivier Malaise; Zelda Plener; Gaël Cobraiville; Christophe Daniel; Philippe Gillet
Journal:  Cell Mol Life Sci       Date:  2022-04-27       Impact factor: 9.207

3.  Attenuation of Radiation-Induced Lung Injury by Hyaluronic Acid Nanoparticles.

Authors:  Anna Lierova; Jitka Kasparova; Jaroslav Pejchal; Klara Kubelkova; Marcela Jelicova; Jiri Palarcik; Lucie Korecka; Zuzana Bilkova; Zuzana Sinkorova
Journal:  Front Pharmacol       Date:  2020-08-12       Impact factor: 5.810

Review 4.  The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19.

Authors:  Nansy Albtoush; Aaron C Petrey
Journal:  Am J Physiol Cell Physiol       Date:  2022-04-20       Impact factor: 5.282

5.  Loss of versican and production of hyaluronan in lung epithelial cells are associated with airway inflammation during RSV infection.

Authors:  Gerald G Kellar; Kaitlyn A Barrow; Lucille M Rich; Jason S Debley; Thomas N Wight; Steven F Ziegler; Stephen R Reeves
Journal:  J Biol Chem       Date:  2020-11-21       Impact factor: 5.157

6.  The Effects of TNF-α Inhibition on the Metabolism of Cartilage: Relationship between KS, HA, HAPLN1 and ADAMTS4, ADAMTS5, TOS and TGF-β1 Plasma Concentrations in Patients with Juvenile Idiopathic Arthritis.

Authors:  Kornelia Kuźnik-Trocha; Katarzyna Winsz-Szczotka; Iwona Lachór-Motyka; Klaudia Dąbkowska; Magdalena Wojdas; Krystyna Olczyk; Katarzyna Komosińska-Vassev
Journal:  J Clin Med       Date:  2022-04-04       Impact factor: 4.241

Review 7.  Pathophysiological and Therapeutic Roles of Fascial Hyaluronan in Obesity-Related Myofascial Disease.

Authors:  Chiedozie Kenneth Ugwoke; Erika Cvetko; Nejc Umek
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

8.  CircHYBID regulates hyaluronan metabolism in chondrocytes via hsa-miR-29b-3p/TGF-β1 axis.

Authors:  Hong-Xing Liao; Zhi-Hui Zhang; Hui-Lin Chen; Ying-Mei Huang; Zhan-Liang Liu; Jian Huang
Journal:  Mol Med       Date:  2021-05-31       Impact factor: 6.354

9.  Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy.

Authors:  Alyson Wolk; Dilara Hatipoglu; Alecia Cutler; Mariya Ali; Lestella Bell; Jian Hua Qi; Rupesh Singh; Julia Batoki; Laura Karle; Vera L Bonilha; Oliver Wessely; Heidi Stoehr; Vincent Hascall; Bela Anand-Apte
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.